New England Capital Financial Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.3K | Buy |
490
+2
| +0.4% | +$222 | 0.02% | 116 |
|
|
2025
Q1 | $54.7K | Sell |
488
-139
| -22% | -$15.6K | 0.03% | 108 |
|
|
2024
Q4 | $57.9K | Sell |
627
-47
| -7% | -$4.34K | 0.03% | 109 |
|
|
2024
Q3 | $56.5K | Buy |
674
+4
| +0.6% | +$335 | 0.03% | 107 |
|
|
2024
Q2 | $46K | Buy |
670
+4
| +0.6% | +$275 | 0.03% | 115 |
|
|
2024
Q1 | $48.8K | Buy |
666
+3
| +0.5% | +$220 | 0.03% | 112 |
|
|
2023
Q4 | $53.7K | Buy |
663
+4
| +0.6% | +$324 | 0.03% | 111 |
|
|
2023
Q3 | $49.4K | Buy |
659
+3
| +0.5% | +$225 | 0.03% | 111 |
|
|
2023
Q2 | $50.5K | Buy |
656
+4
| +0.6% | +$308 | 0.03% | 111 |
|
|
2023
Q1 | $54.1K | Buy |
652
+3
| +0.5% | +$249 | 0.04% | 110 |
|
|
2022
Q4 | $53.9K | Buy |
+649
| New | +$53.9K | 0.04% | 116 |
|